Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - TOTAL EQUITY
Total Equity APLS - Apellis Pharmaceuticals, Inc.
195 M
LAST VALUE
-1.05%
2 YEAR CAGR
3.86%
5 YEAR CAGR
45.67%
10 YEAR CAGR